Interlaboratory Studies Using the NISTmAb to Advance Biopharmaceutical Structural Analytics

Interlaboratory Studies Using the NISTmAb to Advance Biopharmaceutical Structural Analytics

Biopharmaceuticals such as monoclonal antibodies are required to be rigorously characterized using a wide range of analytical methods. Various material properties must be characterized and well controlled to assure that clinically relevant features and critical quality attributes are maintained. A t...

Full description

Bibliographic Details
Main Authors: Katharina Yandrofski, Trina Mouchahoir, M. Lorna De Leoz, David Duewer, Jeffrey W. Hudgens, Kyle W. Anderson, Luke Arbogast, Frank Delaglio, Robert G. Brinson, John P. Marino, Karen Phinney, Michael Tarlov, John E. Schiel
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Molecular Biosciences
Subjects:
monoclonal antibody
biopharmaceutical
nistmab
therapeutic protein
interlaboratory study
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2022.876780/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2022.876780/full

Similar Items